Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-27 @ 4:57 AM
Study NCT ID:
NCT00021034
Status:
COMPLETED
Last Update Posted:
2013-06-18
First Post:
2001-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-03
Start Date Type:
None
Primary Completion Date:
2001-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2001-08
Completion Date Type:
ACTUAL
First Submit Date:
2001-07-11
First Submit QC Date:
None
Study First Post Date:
2004-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-17
Last Update Post Date:
2013-06-18
Last Update Post Date Type:
ESTIMATED